Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers.
Journal: iScience
Published: June 09, 2022
Methods for Studying Mouse and Human Invariant Natural Killer T Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 15, 2021
Targeting monoamine oxidase A for T cell-based cancer immunotherapy.
Journal: Science immunology
Published: February 24, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.
Journal: Cell reports. Medicine
Published: January 28, 2021
Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 24, 2020
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy.
Journal: Nature communications
Published: June 25, 2020
PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells.
Journal: Leukemia
Published: November 27, 2016
Corrigendum: Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells.
Journal: Nature biotechnology
Published: August 08, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026